-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
GoodRx Holdings, Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2019 to Q4 2024.
- GoodRx Holdings, Inc. Costs and Expenses for the quarter ending December 31, 2024 was $180M, a 16.1% decline year-over-year.
- GoodRx Holdings, Inc. Costs and Expenses for the twelve months ending December 31, 2024 was $726M, a 6.54% decline year-over-year.
- GoodRx Holdings, Inc. annual Costs and Expenses for 2024 was $726M, a 6.54% decline from 2023.
- GoodRx Holdings, Inc. annual Costs and Expenses for 2023 was $777M, a 1.63% increase from 2022.
- GoodRx Holdings, Inc. annual Costs and Expenses for 2022 was $765M, a 4.48% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)